e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU
Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel, Alexandre Salé, Baptiste Arnouat, Jean-Louis Bizec, Marie Langelot, Christine Lineau, David Marquette, Françoise Martin, Mathieu Lederlin, Stéphane Jouneau
Source:
Eur Respir J, 56 (5) 2001154; 10.1183/13993003.01154-2020
Journal Issue:
November
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tiphaine Guy, Audrey Créac'hcadec, Charles Ricordel, Alexandre Salé, Baptiste Arnouat, Jean-Louis Bizec, Marie Langelot, Christine Lineau, David Marquette, Françoise Martin, Mathieu Lederlin, Stéphane Jouneau. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Respir J, 56 (5) 2001154; 10.1183/13993003.01154-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
High-flow oxygen therapy in COPD patients: Optimised oxygen delivery
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Transtracheal oxygen therapy as an effective treatment in patients suffering from severe hypoxemia and with high flow oxygen requirement: Description of two cases
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011
High flow heliox therapy
via
nasal cannulae may be safe and more effective than conventional oxygen therapy in infants with respiratory distress: an
in silico
study
Source: Eur Respir J 2007; 30: Suppl. 51, 377s
Year: 2007
High-flow oxygen by nasal cannula: experience of an intensive care unit
Source: International Congress 2019 – New strategies to treat respiratory failure
Year: 2019
Our experience of 200 patients: Usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Apneic oxygenation via nasal prongs at 10 L/min prevents hypoxemia during tracheal intubation for elective surgery
Source: Annual Congress 2013 –Mechanical ventilation and weaning
Year: 2013
Experimental use of CPAP device for emergency high-flow nasal oxygen therapy
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
High-flow oxygen therapy is more effective and less expensive for bronchiolitis than standard low-flow oxygen therapy: A decision analysis
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device
Source: Eur Respir Rev, 26 (145) 170028; 10.1183/16000617.0028-2017
Year: 2017
Continuous positive airway pressure, oxygen therapy or high-flow nasal oxygen therapy in patients with acute COVID-19 lung disease?
Source: Sleep and Breathing Conference 2021
Year: 2021
Overview of the role of high-flow nasal oxygen therapy in acute and chronic respiratory care: has it found its place versus NIV?
Source: Sleep and Breathing Conference 2021
Year: 2021
High-flow nasal cannula heated-humidified (HFNC) oxygen (O2) at 2 litres (lt)/kg/min versus low-flow O2 (up to 2lt/min) in pediatric emergency department (PED) and pediatric ward (PW) in infants with bronchiolitis who need O2 administration: A combined prospective randomized controlled and retrospective study: Preliminary results
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
High-flow nasal cannula therapy versus standard pressure support non-invasive ventilation in treating adult patients with severe asthma exacerbation complicated with respiratory failure
Source: Virtual Congress 2021 – New trends in non-invasive respiratory support
Year: 2021
High flow nasal cannula in patients not suitable for invasive ventilation – are we missing an opportunity for palliative care?
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
Early non-invasive ventilation versus conventional oxygen therapy in immunocompromised patients with respiratory failure: a meta-analysis
Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation
Year: 2017
Benefits of high-flow nasal cannula oxygen therapy on exercise capacity following acute exacerbation in ILD patients
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020
High-flow nasal oxygen versus noninvasive positive airway pressure after surgery
Source: International Congress 2016 – Noninvasive ventilation versus high-flow nasal therapy for hypoxemic patients
Year: 2016
Experience with high-flow nasal oxygen therapy in COVID-19 patients on a regular internal medicine ward
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
Management of the COPD patient with chronic respiratory insufficiency: long-term oxygen therapy, invasive and non-invasive ventilation and other approaches
Source: Annual Congress 2004 - PG4 - Management of end-stage patients with COPD
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept